These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1960959)

  • 21. A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim-Medos Investigator Group.
    Pollack IF; Albright AL; Adelson PD
    Neurosurgery; 1999 Dec; 45(6):1399-408; discussion 1408-11. PubMed ID: 10598708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The complementary role of plain radiographs and radionuclide shuntography in evaluating CSF-VP shunts.
    Blair K; AuCoin R; Kloiber R; Molnar CP
    Clin Nucl Med; 1989 Feb; 14(2):121-3. PubMed ID: 2731390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Complication of a ventriculo-atrial shunt for the treatment of hydrocephalus. Report of an unusual case].
    Villegas-Camargo I; Maldonado-Rayas J; Esguerra-Leyva F; Hurtado-Montalvo JA; Manuel Ruiz-MacĂ­as C; James HE
    Bol Med Hosp Infant Mex; 1987 Feb; 44(2):112-5. PubMed ID: 3548743
    [No Abstract]   [Full Text] [Related]  

  • 24. Does Shunt Selection Affect the Rate of Early Shunt Complications in Neonatal Myelomeningocele-Associated Hydrocephalus? A Multi-Center Study.
    Kahilogullari G; Etus V; Guler TM; Karabagli H; Unlu A
    Turk Neurosurg; 2018; 28(2):303-306. PubMed ID: 27593850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disconnection as a cause of ventriculoperitoneal shunt malfunction in multicomponent shunt systems.
    Aldrich EF; Harmann P
    Pediatr Neurosurg; 1990-1991; 16(6):309-11; discussion 312. PubMed ID: 2134742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid shunt complications: an emergency medicine perspective.
    Key CB; Rothrock SG; Falk JL
    Pediatr Emerg Care; 1995 Oct; 11(5):265-73. PubMed ID: 8570446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The necessity of shunt series.
    Vassilyadi M; Tataryn ZL; Alkherayf F; Udjus K; Ventureyra EC
    J Neurosurg Pediatr; 2010 Nov; 6(5):468-73. PubMed ID: 21039171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management with a programmable pressure valve of subdural hematomas caused by a ventriculoperitoneal shunt: case report.
    Kamano S; Nakano Y; Imanishi T; Hattori M
    Surg Neurol; 1991 May; 35(5):381-3. PubMed ID: 2028387
    [No Abstract]   [Full Text] [Related]  

  • 29. Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 5: Effect of valve type on cerebrospinal fluid shunt efficacy.
    Baird LC; Mazzola CA; Auguste KI; Klimo P; Flannery AM;
    J Neurosurg Pediatr; 2014 Nov; 14 Suppl 1():35-43. PubMed ID: 25988781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining the best cerebrospinal fluid shunt valve design: the pediatric valve design trial.
    Drake JM; Kestle J
    Neurosurgery; 1996 Mar; 38(3):604-7. PubMed ID: 8837819
    [No Abstract]   [Full Text] [Related]  

  • 31. Shunt Devices for Neurointensivists: Complications and Management.
    Smith G; Pace J; Scoco A; Singh G; Kandregula K; Manjila S; Ramos-Estebanez C
    Neurocrit Care; 2017 Oct; 27(2):265-275. PubMed ID: 28243998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjustable vs set-pressure valves decrease the risk of proximal shunt obstruction in the treatment of pediatric hydrocephalus.
    McGirt MJ; Buck DW; Sciubba D; Woodworth GF; Carson B; Weingart J; Jallo G
    Childs Nerv Syst; 2007 Mar; 23(3):289-95. PubMed ID: 17106749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Avoidable factors that contribute to the complications of ventriculoperitoneal shunt in childhood hydrocephalus.
    Choudhury AR
    Childs Nerv Syst; 1990 Sep; 6(6):346-9. PubMed ID: 2257549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of silicone valve housing in a Codman Hakim Precision valve with integrated Siphonguard.
    Woerdeman PA; Cochrane DD
    J Neurosurg Pediatr; 2014 May; 13(5):532-5. PubMed ID: 24635137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of the treatment of hydrocephalus with ventriculo-jugular shunts.
    Beks JW; ter Weeme CA
    Neurochirurgia (Stuttg); 1975 Jul; 18(4):118-20. PubMed ID: 1178099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Micro-fabricated shunt to mimic arachnoid granulations for the treatment of communicating hydrocephalus.
    Kralick F; Oh J; Medina T; Noh HM
    Acta Neurochir Suppl; 2012; 114():239-42. PubMed ID: 22327701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of ventricular catheter obstruction and slit ventricle syndrome by the prophylactic use of the Integra antisiphon device in shunt therapy for pediatric hypertensive hydrocephalus: a 25-year follow-up study.
    Gruber RW; Roehrig B
    J Neurosurg Pediatr; 2010 Jan; 5(1):4-16. PubMed ID: 20043731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The delta valve: how does its clinical performance compare with two other pressure differential valves without antisiphon control?
    Davis SE; Levy ML; McComb JG; Sposto R
    Pediatr Neurosurg; 2000 Aug; 33(2):58-63. PubMed ID: 11070430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parent/guardian knowledge regarding implanted shunt type, setting, and symptoms of malfunction/infection.
    Ackerman LL; Fulkerson DH; Jea A; Smith JL
    J Neurosurg Pediatr; 2018 Apr; 21(4):359-366. PubMed ID: 29328006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrocephalus treatment in children: long-term outcome in 975 consecutive patients.
    Beuriat PA; Puget S; Cinalli G; Blauwblomme T; Beccaria K; Zerah M; Sainte-Rose C
    J Neurosurg Pediatr; 2017 Jul; 20(1):10-18. PubMed ID: 28430083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.